Plan your trading with the latest market research on Crypto, Forex, Stocks, and more, from our team of experts.
Crypto markets consolidated in the early part of the week as traders mostly focused on the strength of the dollar…
After a solid performance in 2023, Ethereum has pushed back above the $2000 psychological level and is closing in on…
The price of BTC jumped early last week after Google updated its advertising policy to allow cryptocurrency trust products to…
As 2022 was a bad year for Bitcoin, 2023 was equally as good. Could 2024 see Bitcoin extend its uptrend?…
Ethereum Classic price has risen 6% over the past week and 16% over the past month as attention turns to…
SEC delays BlackRock’s Ethereum ETF decision, showing caution in evaluating Ethereum Exchange Traded Fund proposals. Fidelity’s Ethereum ETF application is…
After the media discovered that around $1 billion out of $3 billion that GBTC had sold the week before was…
The fixation on short-term spot-Bitcoin ETFs has Bitcoin on track to lose over 4% this week, extending the selloff from…
The main story of last week continues to be cryptocurrency, which has outperformed all asset classes again by posting significant…
SEC approved Spot BTC ETF on Thursday, 11th January Most ETFs saw significant inflows…
Crypto prices continued to plunge last week after a small bounce on Martin Luther King’s holiday when the large institutions…
Following more evident developments that the spot BTC ETFs would be approved, the price of BTC shot higher by almost…
The first week of the new year started with the price of BTC bidding up close to $46,000 as expectations…
Early last week saw yet another flushing out event in the crypto world, with the price of BTC revisiting a…
The information provided here is not an invitation to buy or sell products, nor is it an invitation to make an investment or trading strategy. This should not be seen as financial or investment advice of any kind, nor does Prime XBT endorse or guarantee the relevance, timeliness, or accuracy of the information or publications.
Risk Warning:
Trading in leveraged products carries a high level of risk and may not be suitable for all investors.
